Australian Institute of Health and Welfare (2021) Heart, stroke and vascular disease—Australian facts, AIHW, Australian Government, accessed 08 December 2022.
Australian Institute of Health and Welfare. (2021). Heart, stroke and vascular disease—Australian facts. Retrieved from https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts
Heart, stroke and vascular disease—Australian facts. Australian Institute of Health and Welfare, 29 September 2021, https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts
Australian Institute of Health and Welfare. Heart, stroke and vascular disease—Australian facts [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2022 Dec. 8]. Available from: https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts
Australian Institute of Health and Welfare (AIHW) 2021, Heart, stroke and vascular disease—Australian facts, viewed 8 December 2022, https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts
Get citations as an Endnote file:
PDF | 12.2Mb
On this page
Atrial fibrillation (AF) is a disturbance of the electrical system of the heart, where the heart beats with an abnormal rhythm, and does not pump blood regularly or work as efficiently as it should.
Often, people with AF do not know that they have it, and they do not experience any symptoms. Others may experience an irregular pulse, heart palpitations (‘fluttering’), fatigue, weakness, discomfort, shortness of breath or dizziness.
Common causes of AF include long-term high blood pressure, coronary heart disease and valvular heart disease. For some people, there is no apparent cause.
The risk of developing AF is higher in older people. Other risks include obesity, diabetes, CKD, obstructive sleep apnoea, smoking and alcohol consumption above guideline levels.
AF increases the risk of stroke, and strokes associated with AF are more severe with a risk of death twice that of other stroke causes. An individual’s risk may be even higher if their AF is associated with previous heart disease or with other chronic diseases (NHFA 2016).
Currently, there are no national data sources that report on the total number of Australians who have AF.
Surveys and studies on sections of the Australian population suggest that AF affects approximately 2.2% of the general population—equivalent to more than 500,000 people in 2021 (AIHW 2020).
The proportion affected increases with age. An estimated 5.4% of the Australian population aged 55 and over have AF.
Often, AF can be managed through the primary care that is provided by general practitioners, allied health services, community health services and community pharmacy. However, some patients with AF will need admission to hospital for investigation and management, and they may require surgical or therapeutic procedures during the admission.
Note that the hospitalisation data presented here are based on admitted patient episodes of care, which exclude non-admitted emergency department care, but can include multiple events experienced by the same individual.
Atrial fibrillation often occurs alongside other chronic diseases, so both the principal and additional diagnoses of AF should be counted when estimating its contribution to hospitalisations.
There were around 223,000 hospitalisations where AF was recorded as the principal and/or additional diagnosis in 2018–19. This represents 1.9% of all hospitalisations in Australia.
Atrial fibrillation was recorded as the principal diagnosis in 33% (73,400) of these hospitalisations.
In those cases where AF was listed as an additional diagnosis, common principal diagnoses include other cardiovascular diseases (heart failure, stroke, acute myocardial infarction), pneumonia, sepsis, chronic obstructive pulmonary disease and fracture of femur (AIHW 2020).
Where AF was recorded as the principal and/or additional diagnosis, hospitalisation rates:
The bar chart shows that atrial fibrillation hospitalisation rates in 2018–19 were highest among males and females 85 years and over (10,800 and 9,700 per 100,000 population, respectively).
Between 2000–01 and 2018–19, there was little reduction in the age-standardised rate of hospitalisations with a principal and/or additional diagnosis of AF (748 to 723 per 100,000 population).
The number of AF hospitalisations increased by two-thirds (67%) for males and 48% for females, while rates fell by 3.9% for males (from 911 to 876 per 100,000 population) and 4.9% for females (from 613 to 583 per 100,000 population) (Figure 2).
The hospitalisation rate where AF was the principal diagnosis, however, increased by almost 40%, from 175 to 244 per 100,000 population.
The use of linked hospitalisations data in Western Australia has shown that the increase in that state was driven more by repeat hospitalisations for the same person, rather than new hospitalisations (Briffa et al. 2016, Weber et al. 2019).
The line chart shows that age-standardised atrial fibrillation hospitalisation rates have remained steady between 2000–01 and 2018–19 at around 900 and 600 per 100,000 population for males and females respectively.
Aboriginal and Torres Strait Islander people
In 2018–19, there were around 4,700 hospitalisations with a principal and/or additional diagnosis of AF among Aboriginal and Torres Strait Islander people.
After adjusting for differences in the age structure of the populations:
In 2018–19, age-standardised AF hospitalisation rates were 22% higher for people living in the lowest socioeconomic areas compared with those in the highest socioeconomic areas—796 and 651 per 100,000 population.
For males, the gap in hospitalisations between the lowest and highest socioeconomic areas was 1.2 times as high (947 and 800 per 100,000 population), and for females 1.3 times as high (655 and 513 per 100,000 population) (Figure 3).
In 2018–19, age-standardised AF hospitalisation rates were around 30% higher among those living in Remote and very remote areas compared with those in Major cities (890 and 691 hospitalisations per 100,000 population).
The disparities in male and female rates were similar—male rates were 1.2 times as high in Remote and very remote areas as in Major cities (1,011 and 834 per 100,000 population), while females rates were 1.3 times as high (753 and 562 per 100,000 population) (Figure 3).
The horizontal bar chart shows that age-standardised atrial fibrillation hospitalisation rates in 2018–19 were higher among Indigenous Australians, people living in the lowest socioeconomic areas and people living in Remote and very remote areas.
Atrial fibrillation (AF) contributed to 14,300 deaths (8.6% of all deaths) in 2019.
AF was the underlying cause of 2,200 deaths in 2019, and was an associated cause in a further 12,100 deaths.
AF is far more likely to be listed as an associated cause of death. This is because it is often not AF that leads directly to death—rather, one of its accompanying comorbidities or complications will be listed as the underlying cause of death on the death certificate.
When AF is examined as an associated cause of death, the conditions most commonly listed as the underlying cause of death were other diseases of the circulatory system such as coronary heart disease (CHD) or stroke, as well as chronic obstructive pulmonary disease and dementia (AIHW 2020).
In 2019, age-standardised death rates for AF as the underlying or associated cause:
The bar chart shows that atrial fibrillation death rates in 2019 were highest among males and females 85 and over (1,800 and 1,700 per 100,000 population, respectively).
Between 1997 and 2019:
The line chart shows the increase in age-standardised atrial fibrillation death rates between 1997 and 2019 for both males and females, from 30 to 48 and 23 to 37 per 100,000 population, respectively.
In 2017–2019, AF was the underlying or associated cause of death for 420 Indigenous Australians in the jurisdictions with adequate Indigenous identification.
The age-standardised Indigenous death rate (69 per 100,000 population) was 1.6 times as high as the non-Indigenous rate (44 per 100,000 population). Indigenous males and females had AF death rates 1.4 and 1.8 times as high as non-Indigenous males and females (Figure 6).
In 2017–2019, the age-standardised death rate for AF as an underlying or associated cause was 1.5 times as high for people living in the lowest socioeconomic areas compared with those living in the highest socioeconomic areas (51 and 35 per 100,000 population).
The difference was slightly greater for males (1.5 times as high) than females (1.4 times as high) (Figure 6).
In 2017–2019, age-standardised AF rates were lowest for those living in Major cities (40 deaths per 100,000 population) and highest for those in Remote and very remote areas (53 per 100,000).
Males had higher AF rates than females in all remoteness areas (Figure 6).
The horizontal bar chart shows that age-standardised atrial fibrillation death rates in 2017–2019 were higher among Indigenous Australians, people living in the lowest socioeconomic areas and people living in Remote and very remote areas.
AIHW 2020. Atrial fibrillation in Australia. AIHW cat. no. CDK 17. Canberra: AIHW.
Briffa T, Hung J, Knuiman M, McQuillan B, Chew DP, Eikelboom J, Hankey GJ et al. 2016. Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995–2010. International Journal of Cardiology 208: 19–25.
NHFA (National Heart Foundation of Australia) 2016. Atrial fibrillation: understanding abnormal heart rhythm. Canberra: NHFA.
Weber C, Hung J, Hickling S, Li I, McQuillan B, Briffa T 2019. Drivers of hospitalisation trends for non-valvular atrial fibrillation in Western Australia, 2000–2013. International Journal of Cardiology 276: 273–7.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.